Search This Blog

Thursday, September 8, 2022

Palatin STarts Phase 2 Clinical Study Evaluating Oral PL8177 for Treatment of Ulcerative Colitis

 Study Designed to Evaluate the Safety, Tolerability, and Efficacy with PL8177 Oral Colon Delivery in Adult Subjects with Active Ulcerative Colitis

Oral PL8177 May Provide a Safe and Tolerable Treatment Option for Ulcerative Colitis Patients

https://finance.yahoo.com/news/palatin-announces-initiation-patient-recruitment-113000337.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.